数据显示，国泰基金旗下1只基金重仓平潭发展。国泰中证2000ETF（561370）四季度持有股数9800 股，占基金净值比例为0.48%，位居第二大重仓股。根据测算，今日浮盈赚取约5684元。连续4天上涨 期间浮盈赚取5782元。 国泰中证2000ETF（561370）成立日期2023年9月13日，最新规模3129.37万。今年以来收益13.14%，同 类排名984/5574；近一年收益39.3%，同类排名1360/4326；成立以来收益58.37%。 国泰中证2000ETF（561370）基金经理为麻绎文、刘昉元。 2月27日，平潭发展涨5.25%，截至发稿，报11.63元/股，成交22.13亿元，换手率10.58%，总市值224.67 亿元。平潭发展股价已经连续4天上涨，区间累计涨幅5.64%。 资料显示，中福海峡(平潭)发展股份有限公司位于福建省福州市鼓楼区五四路159号世界金龙大厦23 层，成立日期1993年9月8日，上市日期1996年3月27日，公司主营业务涉及造林营林、林木产品加工与 销售、贸易业务、与平潭综合实验区开放开发的有关业务。主营业务收入构成为：纤维板销售 42.75%，商品房销售36. ...

来源：新浪基金∞工作室 2月27日，中证2000ETF（563300）开盘跌0.64%，报1.545元。中证2000ETF（563300）重仓股方面，鼎 通科技开盘跌3.14%，骄成超声跌2.83%，平潭发展跌2.08%，信息发展跌0.01%，成都先导跌0.79%，华 锐精密跌0.30%，炬芯科技跌0.58%，东田微跌3.44%，卓易信息涨1.71%，神工股份跌2.81%。 中证2000ETF（563300）业绩比较基准为中证2000指数收益率，管理人为华泰柏瑞基金管理有限公司， 基金经理为李沐阳、柳军，成立（2023-09-06）以来回报为55.21%，近一个月回报为2.28%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 ...

2月26日，平潭发展涨5.98%，截至发稿，报11.69元/股，成交9.13亿元，换手率4.20%，总市值225.83亿 元。平潭发展股价已经连续3天上涨，区间累计涨幅5.45%。 资料显示，中福海峡(平潭)发展股份有限公司位于福建省福州市鼓楼区五四路159号世界金龙大厦23 层，成立日期1993年9月8日，上市日期1996年3月27日，公司主营业务涉及造林营林、林木产品加工与 销售、贸易业务、与平潭综合实验区开放开发的有关业务。主营业务收入构成为：纤维板销售 42.75%，商品房销售36.79%，农资贸易流通13.81%，林木产品销售2.34%，生物与新医药产品生产销售 2.22%，不动产租赁0.95%，其他贸易流通0.80%，其他0.32%。 责任编辑：小浪快报 国泰中证2000ETF（561370）基金经理为麻绎文、刘昉元。 截至发稿，麻绎文累计任职时间2年204天，现任基金资产总规模136.57亿元，任职期间最佳基金回报 129.57%， 任职期间最差基金回报-11.89%。 刘昉元累计任职时间322天，现任基金资产总规模14.36亿元，任职期间最佳基金回报60.63%， 任职期 间最差基金回报-8. ...

种业股盘初上扬，新赛股份涨停，新农开发、宏辉果蔬、平潭发展、神农种业、敦煌种业跟涨。 ...

（文章来源：证券日报） 证券日报网讯 2月25日，平潭发展在互动平台回答投资者提问时表示，截至2026年2月13日公司股东人 数为376689户。 ...

格隆汇2月25日丨平潭发展(000592.SZ)在互动平台表示，公司未有开展免税业务，公司主要业务为造林 营林、林木产品加工与销售、贸易业务、与平潭综合实验区开放开发的有关业务。 ...

Core Viewpoint - Pingtan Development (000592.SZ) has clarified that it does not engage in duty-free business, focusing instead on forestry, wood product processing and sales, trade, and activities related to the development of the Pingtan Comprehensive Experimental Zone [1] Group 1 - The company primarily engages in afforestation and forest management [1] - The company is involved in the processing and sales of wood products [1] - The company participates in trade activities [1] Group 2 - The company is associated with the development activities of the Pingtan Comprehensive Experimental Zone [1]

Group 1 - Pingtan Development's stock price fell by 2.34% to 10.84 CNY per share, with a trading volume of 2.133 billion CNY and a turnover rate of 10.13%, resulting in a total market capitalization of 20.941 billion CNY [1] - The stock has experienced a continuous decline for four days, accumulating a total drop of 8.28% during this period [1] - The company, established on September 8, 1993, and listed on March 27, 1996, operates in various sectors including forestry, wood product processing, and trade, with its main revenue sources being fiberboard sales (42.75%), commercial housing sales (36.79%), and agricultural materials trade (13.81%) [1] Group 2 - Southern Fund's Southern CSI 2000 ETF (159531) holds a significant position in Pingtan Development, with 199,500 shares, accounting for 0.42% of the fund's net value, making it the largest holding [2] - The fund has incurred a floating loss of approximately 51,900 CNY today and a total floating loss of 195,500 CNY over the four-day decline [2] - The Southern CSI 2000 ETF was established on September 7, 2023, with a current size of 725 million CNY, and has achieved a year-to-date return of 10.05% [2]

Investment Rating - The industry rating is "Overweight" [3] Core Insights - The report highlights the ongoing active research in life sciences and the rapid integration of biotechnology into economic and social development, providing innovative solutions to major challenges such as health, climate change, resource security, and food security. The National Development and Reform Commission has issued the "14th Five-Year Plan for the Development of the Bioeconomy," indicating a trillion-yuan market potential in the bioeconomy sector [3][4]. Industry Performance - The Huazhong Synthetic Biology Index increased by 0.11% to 1278.44 during the week of February 2-6, 2026, outperforming the Shanghai Composite Index by 1.39 percentage points and the ChiNext Index by 3.40 percentage points [4]. - The report notes that the synthetic biology sector is experiencing a policy dividend, with Shenzhen proposing up to 100 million yuan in support for R&D efforts in the field [8]. Company Developments - Beijing Huaguan Bio completed a multi-hundred million yuan C-round financing to enhance its R&D and production capabilities in the pharmaceutical and health sectors [32]. - Dejin Bio secured several million yuan in A-round financing to advance its recombinant botulinum toxin clinical research and international expansion [33]. - The report mentions that Impossible Foods is leveraging technology to reshape the plant protein market [11]. Market Dynamics - The report indicates that the synthetic biology sector is witnessing a surge in financing, with nearly a hundred companies completing new funding rounds since 2025 [31]. - The top five companies in the synthetic biology sector by stock performance during the week were Pingtan Development (+12%), Jinbo Bio (+12%), Huaxi Bio (+12%), Shandong Heda (+10%), and Yaxiang Co. (+10%) [17]. Policy and Regulatory Developments - The Ministry of Industry and Information Technology announced 35 examples of non-grain bio-based materials, marking a significant step towards establishing a new green development framework [7]. - The National Health Commission approved 22 new food items, including a significant breakthrough in domestic human milk oligosaccharides (HMOs) production [7]. Research and Innovation - Tsinghua University has initiated a national key R&D project focused on the intelligent design principles of efficient microbial chassis cells, aiming for breakthroughs in both fundamental theory and application demonstration [9]. - The report highlights the strategic cooperation between Tianjin University and China National Petroleum Corporation to expand efforts in synthetic biology and related fields [9].

Group 1 - The main stocks with significant capital outflows include Xinyi Technology (-28.83 billion), Zhongji Xuchuang (-15.50 billion), and Aerospace Development (-13.04 billion) [1] - The sectors affected by the capital outflows primarily include communication equipment, internet services, and optical electronics [2][3] - The largest percentage decline in stock prices was observed in Zhejiang Wenlian, which fell by 9.79% [2] Group 2 - Other notable stocks with substantial capital outflows include Guizhou Moutai (-5.44 billion), Sunshine Power (-5.46 billion), and Sanan Optoelectronics (-4.11 billion) [1][3] - The overall trend indicates a negative sentiment in the market, particularly in the communication equipment and internet service sectors [2][3] - The data reflects a broader market trend of capital withdrawal, impacting various industries including agriculture, aerospace, and cultural media [1][2]